Q4 2024 Earnings Call Transcript February 26, 2025 Vir Biotechnology, Inc. beats earnings expectations. Reported EPS is ...

Hepatitis delta virus requires hepatitis B surface antigen to complete its ... to share that our hard work on rightsizing the cost structure, improving efficiencies and making thoughtful ...

These problems can be best addressed by systematic studies of antigen three-dimensional structure and further ... the production of a recombinant hepatitis B virus (HBV) vaccine 3.

Total Revenue of $426.5 Million, a 65% YoY IncreaseFY 2024 GAAP Net Income of $197.7 Million, Including an $84.3 Million Valuation ...

Groundhogs serve as the best non-human model for studying the hepatitis B virus, which causes liver damage and liver ... Attach the material to the lower edge of the structure, and bury it at least 12 ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

A new study that has the potential to change the landscape of hepatitis B transmission in Africa. Researchers conducted an analysis revealing key interventions that could effectively eliminate ...

Researchers at the University of Liverpool have conducted a large-scale analysis that sheds light on the critical steps ...

Worldwide, hepatitis B is thought to be the second deadliest infection; about 5% of the global population are infection and ...

Maternal hepatitis C virus (HCV) RNA titer > 10⁶ International Units (IU)/mL and antepartum bleeding are key predictors of ...

To facilitate the achieving of the goal of “eliminating viral hepatitis as a major public health threat by 2030” set by the World Health Organization, the Chinese Society of Hepatology together with ...